Kevin C. Maki, PhD

President and Chief Scientist
Midwest Biomedical Research
Addison, Illinois, United States

Kevin C Maki, PhD, CLS, FNLA, FTOS, FACN

Kevin C Maki, PhD is the Founder and Chief Scientist for Midwest Biomedical Research (Chicago, Illinois) and MB Clinical Research (Boca Raton, Florida). He specializes in the design and conduct of clinical studies in human nutrition, metabolism and chronic disease risk factor management. Dr Maki also holds an Adjunct Faculty position teaching Biostatistics and Applied Epidemiology at DePaul University. He is a Fellow of the National Lipid Association, The Obesity Society and the American College of Nutrition, as well as a certified Clinical Lipid Specialist and Vice President of the Board of Governors for the Accreditation Council for Clinical Lipidology.

Dr. Maki has participated in more than 300 clinical trials and observational studies as an investigator, consultant or statistician, and published more than 250 scientific papers, books and book chapters. He earned a PhD in Epidemiology from the University of Illinois at Chicago’s School of Public Health, and an MS in Preventive and Rehabilitative Cardiovascular Health from Benedictine University.

Presentation(s):

• Laboratory Management and Statistical Analysis Plans for Clinical Nutrition Studies

  Thursday, July 14, 2022
  12:00 PM – 5:00 PM ET

  Disclosure(s): Acasti Pharma Inc.: Consultant (Ongoing)
  Beren Therapeutics: Consultant (Ongoing)
  Eli Lilly and Co.: Consultant (Ongoing)
  Naturmega: Grant/Research Support (Ongoing)
  New Amsterdam Pharma: Consultant (Ongoing)
  NorthSea Therapeutics: Consultant (Ongoing)
  Novo Nordisk Pharma Inc.: Consultant (Ongoing)
  Pharmavite: Grant/Research Support (Ongoing)

• Data Management Planning and Execution (Laboratory Management and Statistical Analysis Plans for Clinical Nutrition Studies)

  Thursday, July 14, 2022
  2:45 PM – 3:20 PM ET

  Disclosure(s): Acasti Pharma Inc.: Consultant (Ongoing)
  Beren Therapeutics: Consultant (Ongoing)
  Eli Lilly and Co.: Consultant (Ongoing)
  Naturmega: Grant/Research Support (Ongoing)
  New Amsterdam Pharma: Consultant (Ongoing)
  NorthSea Therapeutics: Consultant (Ongoing)
  Novo Nordisk Pharma Inc.: Consultant (Ongoing)
  Pharmavite: Grant/Research Support (Ongoing)

• Session 2 Panel Discussion (Laboratory Management and Statistical Analysis Plans for Clinical Nutrition Studies)

  Thursday, July 14, 2022
  3:20 PM – 3:50 PM ET

  Disclosure(s): Acasti Pharma Inc.: Consultant (Ongoing)
  Beren Therapeutics: Consultant (Ongoing)
  Eli Lilly and Co.: Consultant (Ongoing)
  Naturmega: Grant/Research Support (Ongoing)
  New Amsterdam Pharma: Consultant (Ongoing)
  NorthSea Therapeutics: Consultant (Ongoing)
  Novo Nordisk Pharma Inc.: Consultant (Ongoing)
  Pharmavite: Grant/Research Support (Ongoing)

• Highlights (Laboratory Management and Statistical Analysis Plans for Clinical Nutrition Studies)

  Thursday, July 14, 2022
  3:50 PM – 3:55 PM ET

  Disclosure(s): Acasti Pharma Inc.: Consultant (Ongoing)
  Beren Therapeutics: Consultant (Ongoing)
  Eli Lilly and Co.: Consultant (Ongoing)
  Naturmega: Grant/Research Support (Ongoing)
  New Amsterdam Pharma: Consultant (Ongoing)
  NorthSea Therapeutics: Consultant (Ongoing)
  Novo Nordisk Pharma Inc.: Consultant (Ongoing)
  Pharmavite: Grant/Research Support (Ongoing)